The Lunenfeld-Tanenbaum Research Institute
Donate Now - Mount Sinai Hospital Foundation of Toronto Lunenfeld QR code
Personal tools
Dr. Daniel Drucker
Home Researchers Dr. Daniel Drucker

Dr. Daniel Drucker

dr. daniel drucker.jpg

Research Institute
Mount Sinai Hospital
Joseph & Wolf Lebovic Health Complex
600 University Avenue
Toronto Ontario M5G 1X5

Tel: 416-586-4800 ext.2308
► Send Email


Dr. Daniel J. Drucker


Dr. Daniel Drucker's lab is internationally renowned not only for his research, but as an environment where the clinical relevance of scientific breakthroughs is pursued. His lab has carried out basic science supporting the development of two new classes of therapies for the treatment of type 2 diabetes and a new therapy for patients with short bowel syndrome requiring parenteral nutrition. His research also shows tremendous promise for the treatment of obesity.

Dr. Drucker studies a family of hormones produced in the pancreas, gastrointestinal tract and brain. Controlling blood glucose and insulin secretion, these hormones also regulate our appetite, the absorption of nutrients from the food we eat, and the conversion of those nutrients to energy. In his lab, Dr. Drucker studies the action of hormones that regulate multiple aspects of metabolism. Since enhanced gut hormone action may be beneficial in diabetes, obesity and inflammatory bowel disorders, these hormone analogues have potential to lead to new treatments for diseases that afflict millions of people worldwide.






At a Glance

  • Dr. Daniel Drucker is a clinician-scientist who develops treatments for diabetes, obesity, and intestinal disorders
  • He studies peptide hormones produced in the pancreas, gastrointestinal tract and brain
  • His lab has carried out basic research leading to two new treatments for type 2 diabetes and one new therapy for short bowel syndrome
  • He holds the Canada Research Chair in Regulatory Peptides and the Banting and best Diabetes Centre-Novo Nordisk chair in Incretin biology


Recognition for Dr. Drucker’s research includes:

  • The 2009 Clinical Investigator Award from The Endocrine Society, Washington, USA
  • Recipient of the 2011 Oon International Award for Preventive Medicine, Cambridge University School of Medicine, UK
  • 2014 Banting Medal for Scientific Achievement, American Diabetes Association, USA
  • 2014 Manpei Suzuki International Prize for Diabetes Research, Manpei Suzuki Foundation, Japan
  • 2015 Elected Fellow of the Royal Society of London, UK
  • 2015 Appointed Officer of the Order of Canada


Major Research Activities

A pioneer in diabetes treatment, Dr. Drucker's work has provided important insights leading to the development of new drugs for the treatment of Type 2 diabetes. Currently, his laboratory at the Lunenfeld-Tanenbaum focuses on understanding the molecular biology and physiology of glucagon-like peptides.


Recent Publications



Document Actions
Facebook popup Youtube popup Twitter popup RSS popup